Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: A health technology assessment

Ontario Health Technology Assessment Series

Volumn 17, Issue 5, 2017, Pages 1-142

 

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANADA; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; FEMALE; FOOT AMPUTATION; FUNDING; HEALTH CARE COST; HUMAN; HYPERBARIC CHAMBER; HYPERBARIC OXYGEN THERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SAFETY; PATIENT SATISFACTION; PERSONAL EXPERIENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); WOUND CARE; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; ECONOMICS; ONTARIO; PROCEDURES; WOUND HEALING;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DIABETIC FOOT; HUMANS; HYPERBARIC OXYGENATION; ONTARIO; QUALITY OF LIFE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; WOUND HEALING;

EID: 85044697172     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Canadian Diabetes Association. Diabetes charter backgrounder - Ontario [Internet]. Toronto (ON): The Association; 2015 [cited 2015 Nov 23]. Available from: http://www.diabetes.ca/getmedia/5941b1c2-8b03-45bf-8db0-e18b969d9aa6/diabetes-charter-backgrounder-ontario-english.pdf.aspx
2. Hux JE, Tang M. Patterns of prevalence and incidence of diabetes. In: Hux JE, Booth GL, Slaughter PM, Laupacis A, editors. Diabetes in Ontario: an ICES practice atlas. Toronto (ON): Institute for Clinical Evaluative Sciences; 2003. p. 11-118.
3. Canadian Diabetes Association. A step towards good health [Internet]. Toronto (ON): The Association; 2015 [cited 2015 June]. Available from: http://www.diabetes.ca/diabetes-and-you/healthy-living-resources/foot-care/a-step-towards-good-health
4. American Diabetes Association. Foot complications [Internet]. Alexandria (VA): The Association; c1995-2016 [updated 2015 May 26; cited 2015 Nov 24]. Available from: http://www.diabetes.org/living-with-diabetes/complications/foot-complications/
5. Ontario Wound Care Interest Group. Fewer wounds, faster healing: framework for an Ontario would care strategy [Internet]. Toronto (ON): OntWIG Executive Group; 2012 [cited 2015 Nov 25]. Available from: http://ontwig.rnao.ca/ontwig-framework-document
6. Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. J Affect Disord. 2015;177:7-21.
7. Ndip A, Ebah L, Mbako A. Neuropathic diabetic foot ulcers - evidence-to-practice. Int J Gen Med. 2012;5:129-34.
8. Public Health Agency of Canada. Diabetes in Canada: facts and figures from a public health perspective. Ottawa (ON): The Agency; 2011.
9. Wagner F. The dysvascular foot: a system of diagnosis and treatment. Foot Ankle. 1981;2:64-122.
10. Registered Nurses’ Association of Ontario. Assessment and management of foot ulcers for people with diabetes. 2nd ed. Toronto (ON): The Association; 2013.
11. Liu RT, Kleiman EM, Nestor BA, Cheek SM. The hopelessness theory of depression: A quarter-century in review. Clinical Psychology: Science and Practice. 2015;22(4):345-65.
12. Medical Advisory Secretariat. Negative pressure wound therapy: an evidence update. Ont Health Technol Assess Ser. 2010;10(22):1-28.
13. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. London: The Institute; 2015.
14. Bowering K, Embil JM. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: foot care. Can J Diabetes. 2013;37(suppl 1):S135-49.
15. Huang ET, Mansouri J, Murad MH, Joseph WS, Strauss MB, Tettelbach W, et al. A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Undersea Hyperb Med. 2015;42(3):205-47.
16. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6(1):37-53.
17. Thackham JA, McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: a review. Wound Repair Regen. 2008;16(3):321-30.
18. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;71(2):119-24.
19. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334(25):1642-8.
20. Navarro P, Bornstein S. Hyperbaric oxygen therapy for difficult wound healing in Newfoundland & Labrador [Internet]. St. John’s (NL): Newfoundland & Labrador Centre for Applied Health Research, Memorial University; 2012 [cited 2015 Dec 1]. Available from: http://www.nlcahr.mun.ca/CHRSP/HBOTFULLREPORT.pdf
21. Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011;127 Suppl 1:131S-41S.
22. Ministry of Health and Long-Term Care. Diagnostic and therapeutic procedures [Internet]. Toronto (ON): The Ministry; 2015 [cited 2016 Jul 7]. Available from: http://www.health.gov.on.ca/english/providers/program/ohip/sob/physserv/jdiagth.pdf
23. McGowan J, Sampson M, Salzwedel D, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-6.
24. O’Neill J, Tabish H, Welch V, Petticrew M, Pottie K, Clarke M, et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J Clin Epidemiol. 2014;67(1):56-64.
25. Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Huibers MJH. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry. 2016;15(3):245-58.
26. Higgins JPT, Altman DG, editors, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. London: The Cochrane Collaboration; 2011. Available from: www.cochrane-handbook.org.
27. Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 2. Psychological treatments. Canadian Journal of Psychiatry. 2016;61(9):524-39.
28. Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg. 2003;25(6):513-8.
29. Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg. 2008;47(6):515-9.
30. Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care. 1996;19(12):1338-43.
31. Kessler L, Bilbault P, Ortega F, Grasso C, Passemard R, Stephan D, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care. 2003;26(8):2378-82.
32. Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998-1003.
33. Londahl M, Landin-Olsson M, Katzman P. Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabet Med. 2011;28(2):186-90.
34. Kalani M, Jorneskog G, Naderi N, Lind F, Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications. 2002;16(2):153-8.
35. Fedorko L, Bowen JM, Jones W, Oreopoulos G, Goeree R, Hopkins RB, et al. Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial. Diabetes Care. 2016;39(3):392-9.
36. Cox RC, Olatunji BO. A systematic review of sleep disturbance in anxiety and related disorders. J Anxiety Disord. 2016;37:104-29.
37. MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 6. Special populations: Youth, women, and the elderly. Canadian Journal of Psychiatry. 2016;61(9):588-603.
38. Weledji EP, Fokam P. Treatment of the diabetic foot - to amputate or not? BMC Surg. 2014;14:83.
39. Game FL, Apelqvist J, Attinger C, Hartemann A, Hinchliffe RJ, Londahl M, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev. 2015;32(Suppl 1):154-68.
40. Goldman RJ. Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review. PM R. 2009;1(5):471-89.
41. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;6:CD004123.
42. Stoekenbroek RM, Santema TB, Koelemay MJ, van Hulst RA, Legemate DA, Reekers JA, et al. Is additional hyperbaric oxygen therapy cost-effective for treating ischemic diabetic ulcers? Study protocol for the Dutch DAMOCLES multicenter randomized clinical trial? J Diabetes. 2015;7(1):125-32.
43. Fife CE, Buyukcakir C, Otto GH, Sheffield PJ, Warriner RA, Love TL, et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients. Wound Repair Regen. 2002;10(4):198-207.
44. Strauss MB, Bryant BJ, Hart GB. Transcutaneous oxygen measurements under hyperbaric oxygen conditions as a predictor for healing of problem wounds. Foot Ankle Int. 2002;23(10):933-7.
45. Londahl M, Katzman P, Hammarlund C, Nilsson A, Landin-Olsson M. Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia. 2011;54(1):65-8.
46. National Institute for Health and Care Excellence. Process and methods guides. The guidelines manual: appendix G: methodology checklist [Internet]. London (UK): The Institute; 2012 [cited 2015 May 27]. Available from: http://publications.nice.org.uk/the-guidelines-manual-appendices-bi-pmg6b/appendix-g-methodology-checklist-economic-evaluations
47. Guo S, Counte MA, Gillespie KN, Schmitz H. Cost-effectiveness of adjunctive hyperbaric oxygen in the treatment of diabetic ulcers. Int J Technol Assess Health Care. 2003;19(4):731-7.
48. Chuck AW, Hailey D, Jacobs P, Perry DC. Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. Int J Technol Assess Health Care. 2008;24(2):178-83.
49. Ma L, Li P, Shi Z, Hou T, Chen X, Du J. A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manage. 2013;59(3):18-24.
50. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. ISPOR health economic evaluation publication guidelines—CHEERS Good Reporting Practices Task Force. Value Health. 2013 Mar-Apr;16(2):231-50.
51. Hopkins RB, Burke N, Harlock J, Jegathisawaran J, Goeree R. Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Serv Res. 2015;15:13.
52. Woo KY, Botros M, Kuhnke J, Evans R, Alavi A. Best practices for the management of foot ulcers in people with diabetes. Adv Skin Wound Care. 2013;26(11):512-24; quiz 225-6.
53. Loukine L, Waters C, Choi BC, Ellison J. Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada. Popul Health Metr. 2012;10(1):7.
54. Lind M, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56(12):2601-8.
55. Statistics Canada. Life tables, Canada, provinces and territories, 2009 to 2011. Ottawa (ON): Statistics Canada; 2015.
56. Brownrigg JR, Davey J, Holt PJ, Davis WA, Thompson MM, Ray KK, et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. Diabetologia. 2012;55(11):2906-12.
57. Fortington LV, Geertzen JH, van Netten JJ, Postema K, Rommers GM, Dijkstra PU. Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg. 2013;46(1):124-31.
58. Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med. 2005;22(10): 1306-9.
59. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14(5):235-41.
60. Ontario Ministry of Health and Long-Term Care. Schedule of benefits: physician services under the Health Insurance Act [Internet]. Toronto (ON): The Ministry; 2015 [cited 2015 Jul 28]. Available from: http://www.health.gov.on.ca/english/providers/program/ohip/sob/physserv/sobmaster11062015.pdf
61. Rosella LC, Lebenbaum M, Fitzpatrick T, O’Reilly D, Wang J, Booth GL, et al. Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis. Diabet Med. 2016;33(3):395-403.
62. Statistics Canada. Consumer price index, historical summary [Internet]. Ottawa (ON): Statistics Canada; 2016 [cited 2016 May 13]. Available from: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/econ46a-eng.htm
63. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22(3):382-7.
64. Canadian Institute for Health Information. Cost of a standard hospital stay [Internet]. Ottawa (ON): The Institute; 2016 [cited 2016 May 13]. Available from: http://yourhealthsystem.cihi.ca/hsp/inbrief?lang=en#!/indicators/015/cost-of-a-standard-hospital-stay-cshs/;mapC1;mapLevel2;/
65. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int. 1995;16(7):388-94.
66. Iversen MM, Tell GS, Riise T, Hanestad BR, Ostbye T, Graue M, et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trondelag Health Study, Norway. Diabetes Care. 2009;32(12):2193-9.
67. Morbach S, Furchert H, Groblinghoff U, Hoffmeier H, Kersten K, Klauke GT, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021-7.
68. Jones WS, Patel MR, Dai D, Vemulapalli S, Subherwal S, Stafford J, et al. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J. 2013;165(5)809-15, 815.e1.
69. Waaijman R, de Haart M, Arts ML, Wever D, Verlouw AJ, Nollet F, et al. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care. 2014;37(6):1697-705.
70. Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJ. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments. Diabetes Metab. 2004;30(6):549-56.
71. O’Reilly D, Pasricha A, Campbell K, Burke N, Assasi N, Bowen JM, et al. Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis. Int J Technol Assess Health Care. 2013;29(3):269-81.
72. Statistics Canada. Population by year, by province and territory [Internet]. Ottawa (ON): Statistics Canada; 2015 [cited 2016 May 16]. Available from: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo02a-eng.htm
73. Agence d’evaluation des technologies et des modes d’intervention en sante. Hyberbaric oxygen therapy in Quebec (AETMIS 2000-3 RE). Montreal (QC): The Agency; 2001.
74. Public Health Agency of Canada. Diabetes in Canada: Facts and figures from a public health perspective. Ottawa, ON: Public Health Agency of Canada; 2011.
75. Booth GL, Polsky JY, Gozdyra P, Cauch-Dudek K, Kiran T, Shah BR, et al. Regional measures of diabetes burden in Ontario. Toronto (ON): Institute for Clinical Evaluative Sciences; 2012.
76. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen. 2005;13(3):230-6.
77. Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: the Framingham Heart Study. Diabetes Care. 2015;38(3):482-7.
78. Barham L. Public and patient involvement at the UK National Institute for Health and Clinical Excellence. Patient. 2011;4(1):1-10.
79. Messina J, Grainger DL. A pilot study to identify areas for further improvements in patient and public involvement in health technology assessments for medicines. Patient. 2012;5(3):199-211.
80. Ontario Health Technology Advisory Committee Public Engagement Subcommittee. Public engagement for health technology assessment at Health Quality Ontario—final report from the Ontario Health Technology Advisory Committee Public Engagement Subcommittee. Toronto (ON): Queen’s Printer for Ontario; 2015.
81. Tjornhoj-Thomsen T, Hansen HP. Knowledge in health technology assessment: who, what, how? Int J Technol Assess Health Care. 2011;27(4):324-9.
82. Rowe G, Frewer LJ. A typology of public engagement mechanisms. Sci Technol Hum Values. 2005;30(2):251-90.
83. Brundisini F, Giacomini M, DeJean D, Vanstone M, Winsor S, Smith A. Chronic disease patients’ experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13(15):1-33.
84. Kvale S. Interviews: an introduction to qualitative research interviewing. Thousand Oaks (CA): Sage Publications; 1996.
85. Kuzel AJ. Sampling in qualitative inquiry. In: Miller WL, Crabtree BF, editors. Doing qualitative research. Thousand Oaks (Ca): Sage Publications; 1999. p. 33-45.
86. Morse J. Emerging from the data: cognitive processes of analysis in qualitative research. In: Morse J, editor. Critical issues in qualitative research methods. Thousand Oaks (CA): Sage Publications; 1994. p. 23-41.
87. Patton MQ. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks (CA): Sage Publications; 2002.
88. Strauss AL, Corbin JM. Basics of qualitative research: techniques and procedures of developing a grounded theory. 2nd ed. Thousand Oaks (CA): Sage Publications; 1998.
89. Health Technology Assessment International Interest Group on Patient and Citizen Involvement in HTA. Introduction to health technology assessment [Internet]. Edmonton (AB): Health Technology Assessment International; 2015 [cited 2015 Aug 5]. Available from: http://www.htai.org/fileadmin/HTAiFiles/ISG/PatientInvolvement/v2files/Resource/PCISG-Resource-IntrotoHTAKFaceyJun13.pdf
90. Strauss AL, Corbin JM. Grounded theory research: procedures, canons, and evaluative criteria. Qual Sociol. 1990;13(1):3-21.
91. Strauss AL, Corbin JM. Grounded theory methodology: an overview. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Thousand Oaks (CA): Sage Publications; 1994. p. 273-85.
92. Bishop AJ, Mudge E. Diabetic foot ulcers treated with hyperbaric oxygen therapy: a review of the literature. Int Wound J. 2014;11(1):28-34.
93. Fonagy P, Cottrell D, Phillips J, Bevington D, Glaser D, Allison E. What works for whom? A critical review of treatments for children and adolescents., 2nd ed. New York, NY: Guilford Press; US; 2015.
94. Hailey D, Jacobs P, Perry DC, Chuck AW, Morrison A, Boudreau R. Hyperbaric oxygen therapy for diabetic foot ulcer. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2007.
95. Hinchliffe RJ, Valk GD, Apelqvist J, Armstrong DG, Bakker K, Game FL, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008;24(Suppl 1):S119-44.
96. Liu R, Li L, Yang M, Boden G, Yang G. Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc. 2013;88(2):166-75.
97. Medical Advisory Secretariat. Hyperbaric oxygen therapy for non-healing ulcers in diabetes mellitus: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(11):1-28.
98. Ritchie K, Bakker S, Craig J, Macpherson K, Mandava L, McIntosh H, et al. The clinical and cost effectiveness of hyperbaric oxygen therapy. Edinburgh (Scotland): NHS Quality Improvement Scotland; 2008.
99. Roeckl-Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg. 2005;92(1):24-32.
100. Stoekenbroek RM, Santema TB, Legemate DA, Ubbink DT, van den Brink A, Koelemay MJ. Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg. 2014;47(6):647-55.
101. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380-2.
102. Canadian Institute for Health Information. Canadian classification of health interventions, volume 3 [Internet]. Ottawa (ON): The Institute; 2010. Available from: https://www.cihi.ca/en/ccivolumethree2015en.pdf